CXL-1020

DB15326InvestigationalSmall molecule

CXL-1020 is under investigation in clinical trial NCT01092325 (Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure).

Formula / weight: C₇H₉NO₅S₂ · 251.27 g/mol (avg)
Code names: CXL-1020

Resolves to

Compound

UNIIT7Q0XY74OKCAS950834-06-7

Structure

InChIKeyRZRWBKKAFHXNEQ-UHFFFAOYSA-NSMILESCS(=O)(=O)C1=CC=CC=C1S(=O)(=O)NO

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of CXL-1020, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account